Technician reacts to Gilead earnings and the biotech space

Carter Worth, Cornerstone Macro, reacts to Gilead earnings and whether investors should trust the biotech bounce. With CNBC's Meg Tirrell and Melissa Lee, and the Fast Money traders, Tim Seymour, Karen Finerman, Dan Nathan and Steve Grasso.
05:19
Thu, Oct 25 20185:41 PM EST